BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25723300)

  • 1. Letter to the Editor: Fusion antibody Fc-endostatin.
    Hueng DY; Sytwu HK
    J Neurosurg; 2015 May; 122(5):1249. PubMed ID: 25723300
    [No Abstract]   [Full Text] [Related]  

  • 2. Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin.
    Grossman R; Tyler B; Hwang L; Zadnik P; Lal B; Javaherian K; Brem H
    J Neurosurg; 2011 Dec; 115(6):1139-46. PubMed ID: 21923243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endostatin reduces vascularization, blood flow, and growth in a rat gliosarcoma.
    Sorensen DR; Read TA; Porwol T; Olsen BR; Timpl R; Sasaki T; Iversen PO; Benestad HB; Sim BK; Bjerkvig R
    Neuro Oncol; 2002 Jan; 4(1):1-8. PubMed ID: 11772427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacy improved by local delivery of species-specific endostatin.
    Huszthy PC; Brekken C; Pedersen TB; Thorsen F; Sakariassen PO; Skaftnesmo KO; Haraldseth O; Lønning PE; Bjerkvig R; Enger PO
    J Neurosurg; 2006 Jan; 104(1):118-28. PubMed ID: 16509155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravital microscopy reveals novel antivascular and antitumor effects of endostatin delivered locally by alginate-encapsulated cells.
    Read TA; Farhadi M; Bjerkvig R; Olsen BR; Rokstad AM; Huszthy PC; Vajkoczy P
    Cancer Res; 2001 Sep; 61(18):6830-7. PubMed ID: 11559558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simulation of tumor-induced angiogenesis and its response to anti-angiogenic drug treatment: mode of drug delivery and clearance rate dependencies.
    Tee D; DiStefano J
    J Cancer Res Clin Oncol; 2004 Jan; 130(1):15-24. PubMed ID: 14586644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin.
    Morbidelli L; Donnini S; Chillemi F; Giachetti A; Ziche M
    Clin Cancer Res; 2003 Nov; 9(14):5358-69. PubMed ID: 14614021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endostatin and anastellin inhibit distinct aspects of the angiogenic process.
    Neskey DM; Ambesi A; Pumiglia KM; McKeown-Longo PJ
    J Exp Clin Cancer Res; 2008 Nov; 27(1):61. PubMed ID: 18983664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ; Bae J; Shin TH; Kang SH; Jeong M; Han Y; Park JH; Kim SK; Kim YS
    J Control Release; 2015 Oct; 216():56-68. PubMed ID: 26260451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microspheres made by w/o/o emulsion method with reduced initial burst for long-term delivery of endostar, a novel recombinant human endostatin.
    Wu J; Wu L; Xu X; Xu X; Yin X; Chen Y; Hu Y
    J Pharm Sci; 2009 Jun; 98(6):2051-8. PubMed ID: 18823006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma.
    Sorensen DR; Leirdal M; Iversen PO; Sioud M
    Neoplasia; 2002; 4(6):474-9. PubMed ID: 12407440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the relationship between MR estimates of blood oxygen saturation and hypoxia: effect of an antiangiogenic treatment on a gliosarcoma model.
    Lemasson B; Christen T; Serduc R; Maisin C; Bouchet A; Le Duc G; Rémy C; Barbier EL
    Radiology; 2012 Dec; 265(3):743-52. PubMed ID: 22996750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Linking antibody Fc domain to endostatin significantly improves endostatin half-life and efficacy.
    Lee TY; Tjin Tham Sjin RM; Movahedi S; Ahmed B; Pravda EA; Lo KM; Gillies SD; Folkman J; Javaherian K
    Clin Cancer Res; 2008 Mar; 14(5):1487-93. PubMed ID: 18316573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous inhibitors of angiogenesis in malignant gliomas: nature's antiangiogenic therapy.
    Rege TA; Fears CY; Gladson CL
    Neuro Oncol; 2005 Apr; 7(2):106-21. PubMed ID: 15831230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endostatin: are we waiting for Godot?
    Whitworth A
    J Natl Cancer Inst; 2006 Jun; 98(11):731-3. PubMed ID: 16757695
    [No Abstract]   [Full Text] [Related]  

  • 16. Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system.
    Reijerkerk A; Mosnier LO; Kranenburg O; Bouma BN; Carmeliet P; Drixler T; Meijers JC; Voest EE; Gebbink MF
    Mol Cancer Res; 2003 Jun; 1(8):561-8. PubMed ID: 12805403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.
    Badruddoja MA; Krouwer HG; Rand SD; Rebro KJ; Pathak AP; Schmainda KM
    Neuro Oncol; 2003 Oct; 5(4):235-43. PubMed ID: 14565159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant human endostatin induces apoptosis of human umbilical venous endothelial cells].
    Yang F; He YL
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):978-80. PubMed ID: 16864091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endostatin Prevents Dietary-Induced Obesity by Inhibiting Adipogenesis and Angiogenesis.
    Wang H; Chen Y; Lu XA; Liu G; Fu Y; Luo Y
    Diabetes; 2015 Jul; 64(7):2442-56. PubMed ID: 25605807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin Fc domain fusion to apolipoprotein(a) kringle V significantly prolongs plasma half-life without affecting its anti-angiogenic activity.
    Yu HK; Lee HJ; Ahn JH; Lim IH; Moon JH; Yoon Y; Yi LS; Kim SJ; Kim JS
    Protein Eng Des Sel; 2013 Jun; 26(6):425-32. PubMed ID: 23571426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.